Bullish vs. Bearish (1 opinions)
Social Sentiment -0.89
ALBO Forecast and Technical Stock Analysis
Sell candidate since 2020-01-23 Loss -2.11% PDF
Albireo Pharma Inc fell by -2.11% in the last day ( Friday, 24th Jan 2020 ) from $23.65 to $23.15 and has now fallen 6 days in a row. During the day the stock fluctuated 3.98% from a day low at $23.01 to a day high of $23.93. The price has fallen in 7 of the last 10 days and is down by -11.44% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -126 449 shares and in total 30 344 shares bought and sold for approximately $702 464.00.
- 30 day high of the ALBO stock price was $28.25 and low was $23.01.
- 90 day high was $30.24 and low was $17.50.
- 52 week high for Albireo Pharma Inc - $38.69 and low - $16.13.
Albireo Pharma Inc has broken the very wide and strong rising short-term trend down. This signalize a slower rising rate, but may also be an early warning about a possible trend shift. Due to trend being broken there will now be resistance at the bottom line of the trend at $24.26. A reaction back to this level may hold a second chance to get out before further falls.
There are few to none technical positive signals at the moment. Albireo Pharma Inc holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $24.58 and $24.03. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Monday January 13, 2020, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Relative Strength Index (RSI)
RSImin/max Values: [ 20 - 75 ]
RSI14 is 45 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $20.82 and $20.80.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Albireo Pharma Inc finds support just below today's level at $20.82. If this is broken, then the next support from accumulated volume will be at $20.80 and $18.08.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.91 between high and low, or 3.98%. For the last week the stock has had a daily average volatility of 4.77%.
Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.
4.77 %Average volatility
Very Low Low Medium High Very High
The Albireo Pharma Inc stock holds several negative signals and despite the positive trend we believe Albireo Pharma Inc will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate candidate.
|ALBO $23.15 ($-0.50 -2.11%)|
ALBO is down $0.50 today, but where's it headed in 2020?
|Zacks Investment Research is releasing its prediction for ALBO based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ALBO analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.